Cynthia Lavoie
Directeur/Bestuurslid bij PROFOUND MEDICAL CORP.
Vermogen: 48 180 $ op 30-04-2024
Oorsprong van het eerstegraads netwerk van Cynthia Lavoie
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 16 | |
Cytochroma, Inc.
 Cytochroma, Inc. Pharmaceuticals: MajorHealth Technology Cytochroma, Inc. is a clinical-stage specialty pharmaceutical company. It develops and markets prescription products for the prevention of vitamin D insufficiency. The firm specializes in pharmaceutical products to treat and prevent secondary hyperparathyroidism associated with chronic kidney disease. The company was founded by Martin J. Petkovich in 1996 and is headquartered in Markham, Canada.
4
| Extinct | Pharmaceuticals: Major | 4 |
Delta TpX, Inc.
 Delta TpX, Inc. Pharmaceuticals: OtherHealth Technology Delta TpX, Inc. develops oncology therapeutics. The American company was founded by Everett Stone, Aaron Schuchart, Cynthia Lavoie, David G. Lowe. David G. Lowe has been the CEO since incorporation.
4
| Holding Company | Pharmaceuticals: Other | 4 |
FAAH Pharma, Inc.
 FAAH Pharma, Inc. BiotechnologyHealth Technology FAAH Pharma, Inc. operates as a project-focused company developing a clinical asset initially for postherpetic neuralgia. The company was founded on June 26, 2014 and is headquartered in Montreal, Canada.
3
| Holding Company | Biotechnology | 3 |
TVM Life Science Management, Inc.
2
| Subsidiary | Investment Managers | 2 |
AllosteRx Capital Management (Canada), Inc.
2
| Private Company | 2 | |
Fibrocor Therapeutics LP
 Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Kaneq Bioscience Ltd.
 Kaneq Bioscience Ltd. BiotechnologyHealth Technology Kaneq Bioscience Ltd. operates as a biotechnology company focuses on developing treatments for type 2 diabetes. The firm develops a protein tyrosine phosphatase1B inhibitor for treating type 2 diabetes mellitus. The company was founded by Jean Bourgouin on October 19, 2012 and is headquartered in Montreal, Canada.
2
| Holding Company | Biotechnology | 2 |
Anchor Therapeutics, Inc.
 Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
CCRM Enterprises Inc
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Cynthia Lavoie via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BOSTON SCIENTIFIC CORPORATION | Medical Specialties | Chief Tech/Sci/R&D Officer Sales & Marketing | |
Forticell Bioscience, Inc.
 Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Biotechnology | Director/Board Member | |
| LIMINAL BIOSCIENCES INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Founder Corporate Officer/Principal | |
| MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
CDP Capital Private Equity
 CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London. | Investment Managers | President Private Equity Investor | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
BDC Venture Capital
 BDC Venture Capital Investment ManagersFinance BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada. | Investment Managers | Director/Board Member Private Equity Investor | |
| University of Toronto | College/University | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| MITSUBISHI CHEMICAL GROUP CORPORATION | Chemicals: Major Diversified | Corporate Officer/Principal | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials. | Biotechnology | Chief Executive Officer Director/Board Member | |
API Corp.
 API Corp. Pharmaceuticals: MajorHealth Technology API Corp. engages in the manufacture and sale of drug substances, pharmaceutical formulation intermediates, investigational drug manufacturing and others. The company was founded in 2002 and is headquartered in Tokyo, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| University of Leiden | College/University | Doctorate Degree Doctorate Degree | |
Qualicaps Co., Ltd.
 Qualicaps Co., Ltd. Pharmaceuticals: MajorHealth Technology Qualicaps Co., Ltd. manufactures and markets hard gelatin and HPMC capsules, capsule filling equipment, and sealing machinery. Its products include pharmaceutical and health food capsules, capsule filling machines, capsule filling machine auger type, capsule weight inspection machine, laser imprinting system, and tablet imprinting machine. The company was founded on April 26, 1965 and is headquartered in Yamatokoriyama, Japan. | Pharmaceuticals: Major | Director/Board Member | |
| Kobe University | College/University | Masters Business Admin | |
| Nagoya University | College/University | Doctorate Degree | |
| Weizmann Institute of Science | College/University | Graduate Degree | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Director/Board Member | |
LSI Medience Corp.
 LSI Medience Corp. Medical SpecialtiesHealth Technology LSI Medience Corp. engages in the clinical examination business. It also engages in the diagnostic agent and drug discovery support business. The company was founded on April 1, 2014 and is headquartered in Tokyo, Japan. | Medical Specialties | Director/Board Member | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Interface Biologics, Inc.
 Interface Biologics, Inc. Information Technology ServicesTechnology Services Interface Biologics, Inc. operates as a commercial stage privately held company that develops transformative biomedical polymer technologies to improve the safety and effectiveness of medical devices. It provides technologies to medical device manufacturers and drug companies. The company was founded by Paul J. Santerre in December 2001 and is headquartered in Toronto, Canada. | Information Technology Services | Chairman Director/Board Member | |
LifeBond Ltd.
 LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Medical Specialties | Chairman | |
| EVOGENE LTD. | Biotechnology | Director/Board Member | |
| HBL - HADASIT BIO-HOLDINGS LTD | Investment Managers | Chairman | |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chairman | |
Toronto Innovation Acceleration Partners
 Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
| Mindsense Biosystems Ltd. | President | ||
| Kyoto Pharmaceutical University | College/University | Graduate Degree | |
Bio-MarCare Technologies Ltd.
 Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel. | Medical/Nursing Services | Director/Board Member | |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
The Kaiteki Institute, Inc.
 The Kaiteki Institute, Inc. Miscellaneous Commercial ServicesCommercial Services The Kaiteki Institute, Inc. engages in the research and investigation of social trends. It also involves in the research and development of new enterprises and operation and management of contract research. The company was founded on April 1, 2009 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
Xagenic, Inc.
 Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Chief Executive Officer | |
Centre For Commercialization of Regenerative Medicine
 Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Dynamic Memory Medical Technologies Ltd. | Director/Board Member | ||
Conavi Medical, Inc.
 Conavi Medical, Inc. Medical SpecialtiesHealth Technology Conavi Medical, Inc. develops, manufactures, sells, and supports technologies to help guide minimally invasive procedures. It provides imaging devices for use during procedures performed by electrophysiologists and interventional cardiologists. The company was founded by Brian Courtney and Amandeep Thind in 2007 and is headquartered in Toronto, Canada. | Medical Specialties | Chairman Director/Board Member | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Life Science Institute, Inc.
 Life Science Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Life Science Institute, Inc. provides clinical testing and pharmaceutical development support activities. The company is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Chief Executive Officer | |
Amplitude Ventures
 Amplitude Ventures Investment ManagersFinance Amplitude Ventures is a venture capital firm. The firm was founded in 2018. It’s headquartered in Montreal, Canada. | Investment Managers | Founder Consultant / Advisor | |
| Sophren, Inc. | Director/Board Member | ||
Baylis Medical Co., Inc.
 Baylis Medical Co., Inc. Medical SpecialtiesHealth Technology Baylis Medical Co., Inc. manufactures pain management and radiology products. The company was founded by Gloria Baylis in 1986 and is headquartered in Montréal, Canada. | Medical Specialties | Corporate Officer/Principal Founder |
Statistieken
Internationaal
| Canada | 20 |
| Verenigde Staten | 11 |
| Japan | 11 |
| Israël | 11 |
| Nederland | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 9 |
| Finance | 6 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 227 |
| Corporate Officer/Principal | 67 |
| Chief Executive Officer | 41 |
| Chairman | 34 |
| Independent Dir/Board Member | 25 |
Sterkste connecties
| Insiders | |
|---|---|
| Raf Hofstein | 36 |
| Luc Marengère | 31 |
| Ken Galbraith | 30 |
| Arthur Rosenthal | 26 |
| Aaron Davidson | 24 |
| Jean-François Pariseau | 24 |
| Franz Hefti | 23 |
| Michael Berendt | 20 |
| David G. Lowe | 19 |
| Gosse Bote Bruinsma | 16 |
| Arun Menawat | 16 |
| Gail Farfel | 15 |
| Brendan M. O'Leary | 15 |
| Andre Hoekema | 14 |
| Michael May | 14 |
- Beurs
- Insiders
- Cynthia Lavoie
- Bedrijfsconnecties
